000			10080nam a22005053i 4500
001			EBC6187166
003			MiAaPQ
005			20240724114240.0
006			m o d |
007			cr cnu||||||||
008			240724s2017 xx o ||||0 eng d
020			_a9783132411432 _q(electronic bk.)
020			_z9783132410657
035			_a(MiAaPQ)EBC6187166
035			_a(Au-PeEL)EBL6187166
035			_a(OCoLC)1153837781
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRM301.12 _b.L855 2018
082	0		_a615.1
100	1		_aLüllmann, Heinz.
245	1	0	_aColor Atlas of Pharmacology.
250			_a5th ed.
264		1	_aStuttgart : _bThieme Medical Publishers, Incorporated, _c2017.
264		4	_c©2018.
300			_a1 online resource (446 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aColor Atlas of Pharmacology -- At a glance -- Title Page -- Copyright -- Contents -- Preface -- Dedication -- General Pharmacology -- 1 History of Pharmacology -- 1.1 History of Pharmacology -- 2 Drug Sources -- 2.1 Drug and Active Principle -- 2.2 Plants as Sources of Effective Medicines -- 2.3 Human Proteins as Medicines -- 2.4 Drug Development -- 2.5 Drug Benefit Assessment -- 2.6 Congeneric Drugs and Name Diversity -- 3 Drug Administration -- 3.1 Oral Dosage Forms -- 3.2 Drug Administration by Inhalation -- 3.3 Dermatological Agents -- 3.4 Distribution in the Body -- 4 Cellular Sites of Action -- 4.1 Targets of Drug Action -- 5 Distribution in the Body -- 5.1 External Barriers of the Body -- 5.2 Blood-Tissue Barriers -- 5.3 Membrane Permeation -- 5.4 Drug Transporters -- 5.5 Distribution of Drugs -- 5.6 Binding of Drugs to Plasma Proteins -- 6 Drug Elimination -- 6.1 The Liver as an Excretory Organ -- 6.2 Biotransformation of Drugs -- 6.3 Drug Metabolism by CYP -- 6.4 Enterohepatic Circulation -- 6.5 The Kidney as an Excretory Organ -- 6.6 Presystemic Elimination -- 7 Pharmacokinetics -- 7.1 Drug Concentration in the Body -- 7.2 Time Course of Drug Concentration -- 7.3 Time Course during Repeated Dosing -- 7.4 Accumulation -- 8 Quantification of Drug Action -- 8.1 Dose-Response Relationship -- 8.2 Concentration-Effect Relationship -- 8.3 Concentration-Binding Curves -- 9 Drug-Receptor Interaction -- 9.1 Types of Binding Forces -- 9.2 Agonists-Antagonists -- 9.3 Enantioselectivity of Drug Action -- 9.4 Receptor Types -- 9.5 G-Protein-coupled Receptors -- 9.6 Plasma Concentration and Effect -- 10 Adverse Drug Effects -- 10.1 Adverse Drug Effects: Causes -- 10.2 Drug Allergy -- 10.3 Cutaneous Reactions -- 10.4 Pregnancy and Lactation -- 10.5 Genetic Variation of Drug Effects -- 11 Drug-independent Effects -- 11.1 Placebo Therapy.
505	8		_aSystems Pharmacology -- 12 Sympathetic Nervous System -- 12.1 Function of the Sympathetic System -- 12.2 Structure of the Sympathetic Nervous System -- 12.3 Adrenoceptor Subtypes and Catecholamine Actions -- 12.4 Sympathomimetics -- 12.5 Indirect Sympathomimetics -- 12.6 α-Sympathomimetics, α-Sympatholytics -- 12.7 ß-Sympatholytics (ß-blockers) -- 13 Parasympathetic Nervous System -- 13.1 Parasympathetic Functions -- 13.2 Cholinergic Synapse -- 13.3 Parasympathomimetics -- 13.4 Parasympatholytics -- 14 Biogenic Amines -- 14.1 Dopamine -- 14.2 Histamine -- 14.3 Serotonin -- 14.4 Substance P and Amino Acids -- 15 Vasodilators -- 15.1 Vasodilators-Overview -- 15.2 Organic Nitrates -- 15.3 Calcium Antagonists -- 16 Inhibitors of the Renin-Angiotensin-Aldosterone System -- 16.1 ACE Inhibitors -- 17 Drugs Acting on Smooth Muscle -- 17.1 Drugs Acting on Smooth Muscle -- 18 Cardiac Drugs -- 18.1 Cardiac Drugs-Overview -- 18.2 Cardiac Glycosides -- 18.3 Antiarrhythmic Drugs -- 19 Antianemic Agents -- 19.1 Treatment of Anemias -- 19.2 Iron Compounds -- 20 Antithrombotic Agents -- 20.1 Thrombosis Therapy -- 20.2 Vitamin K Antagonists and Vitamin K -- 20.3 Heparin -- 20.4 Fibrinolytics -- 20.5 Inhibitors of Platelet Aggregation -- 21 Plasma Volume Expanders -- 21.1 Plasma Volume Expanders -- 22 Drugs Used in Hyperlipoproteinemias -- 22.1 Lipid-lowering Agents -- 23 Diuretics -- 23.1 Diuretics-Overview -- 23.2 NaCl and Water Reabsorption in the Kidney -- 23.3 Diuretics of the Sulfonamide Type -- 23.4 Potassium-sparing Diuretics and Vasopressin -- 24 Water and Electrolyte Disorders -- 24.1 Water and Electrolyte Disorders -- 25 Gastrointestinal Tract -- 25.1 Treatment of Hyperacidity, Use of Laxatives -- 25.2 Antidiarrheal Agents -- 26 Drugs Affecting the Motor System -- 26.1 Motor System -- 26.2 Muscle Relaxants -- 27 Drugs for the Suppression of Pain (Analgesics).
505	8		_a27.1 Nociceptors and Pain Pathways -- 27.2 Eicosanoids -- 27.3 Antipyretic Analgesics -- 27.4 Local Anesthetics -- 27.5 Opioids -- 28 Drugs Acting on the Central Nervous System -- 28.1 General Anesthesia and General Anesthetic Drugs -- 28.2 Inhalational Anesthetics -- 28.3 Injectable Anesthetics -- 28.4 Anxiolytics -- 28.5 Pharmacokinetics of Benzodiazepines -- 28.6 Therapy of Depressive Illness -- 28.7 Therapy of Manic States -- 28.8 Therapy of Schizophrenia -- 29 Drugs Affecting the Endocrine System -- 29.1 Hypothalamic and Hypophyseal Hormones -- 29.2 Thyroid Hormone Therapy -- 29.3 Hyperthyroidism and Antithyroid Drugs -- 29.4 Glucocorticoid Therapy -- 29.5 Androgens, Anabolic Steroids, Antiandrogens -- 29.6 Follicular Growth and Ovulation -- 29.7 Oral Contraceptives -- 29.8 Antiestrogen and Antiprogestin Active Principles -- 29.9 Aromatase Inhibitors -- 29.10 Insulin Formulations -- 29.11 Treatment of Diabetes Mellitus -- 29.12 Type II Diabetes Mellitus -- 29.13 Oral Antidiabetic Drugs -- 29.14 Maintaining Calcium Homeostasis -- 30 Antibacterial Drugs -- 30.1 Drugs for Treating Bacterial Infections -- 30.2 Inhibitors of Cell Wall Synthesis -- 30.3 Pore Formers and Inhibitors of THF Synthesis -- 30.4 Inhibitors of DNA Function -- 30.5 Inhibitors of Protein Synthesis -- 30.6 Drugs for Treating Mycobacterial Infections -- 31 Antifungal Drugs -- 31.1 Drugs Used in the Treatment of Fungal Infections -- 32 Antiviral Drugs -- 32.1 Pharmacotherapy of Viral Infections -- 32.2 Drugs for the Treatment of HIV -- 33 Antiparasitic Drugs -- 33.1 Endo- and Ectoparasites -- 34 Tropical Diseases -- 34.1 Antimalarial Drugs -- 34.2 Other Tropical Diseases -- 35 Anticancer Drugs -- 35.1 Cytostatics -- 35.2 Interference with Cell Proliferation Signaling Pathways -- 35.3 Special Antineoplastic Drug Actions -- 36 Immune Modulators -- 36.1 Inhibition of Immune Responses.
505	8		_a36.2 Calcineurin Inhibitors, Sirolimus -- 37 Antidotes -- 37.1 Antidotes and Treatment of Poisoning -- 38 "Recreational" Drugs -- 38.1 Psychotomimetics -- 38.2 Tobacco and Nicotine -- 38.3 Consequences of Tobacco Smoking -- 38.4 Alcohol Abuse -- Therapy of Selected Diseases -- 39 Cardiovascular Diseases -- 39.1 Hypertension -- 39.2 Angina Pectoris -- 39.3 Antianginal Drugs -- 39.4 Acute Coronary syndrome-Myocardial Infarction -- 39.5 Congestive Heart Failure -- 39.6 Septic Shock -- 40 Neurological Diseases -- 40.1 Parkinson Disease -- 40.2 Epilepsy -- 40.3 Migraine -- 40.4 Emesis -- 40.5 Sleep Disorders -- 41 Eye Diseases -- 41.1 Glaucoma -- 42 Bone Disorders -- 42.1 Osteoporosis -- 43 Metabolic Disorders -- 43.1 Gout -- 43.2 Obesity -- 44 Immune Disorders -- 44.1 Atopy and Antiallergic Therapy -- 44.2 Bronchial Asthma -- 44.3 COPD -- 44.4 Rheumatoid Arthritis -- 44.5 Chronic Inflammatory Bowel Disease -- 44.6 Multiple Sclerosis -- Further Reading -- 45 Further Reading -- Glossary -- 46 Glossary -- Drug Index -- 47 Drug Index -- 47.1 Antibodies -- 47.2 Kinase Inhibitors -- 47.3 Drug Names → Trade Names -- 47.4 Trade Names → Drug Names -- Abbreviations -- 48 Abbreviations -- Subject Index.
520			_aThe Fifth Edition of Luellmann's Color Atlas of Pharmacology has been extensively revised to include all recent advances and new drugs, and the illustrations have been optimized and updated. Each two-page spread presents concise text on the left complemented by detailed full-color illustrations on the right to help users quickly digest important facts and concepts. Color-coded sections provide readers with a helpful framework with which to approach the latest developments in pharmacology. Part 1, General Pharmacology, explains basic aspects, such as drug absorption, distribution, and elimination, along with the molecular mechanisms of drug actions Part 2, Systems Pharmacology, presents the different groups of drugs, emphasizing their functional and therapeutic aspects Part 3, Therapy of Selected Diseases, provides all the relevant information regarding the pharmacological treatment of a large number of conditions Key features: User-friendly format ideal for study and review, self-assessment, and quick reference Completely revised and updated, with 174 color plates New glossary of important and interesting pharmacological terms Updated detailed drug indexes containing current information on drugs listed by both generic and brand names The Fifth Edition of Color Atlas of Pharmacology is an essential study guide and reference for every student, nurse, and practicing physician needing to keep up to date with recent advances in the field.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aPharmacology--Atlases.
650		0	_aPharmacology--Handbooks, manuals, etc.
650		0	_aPharmacology.
655		4	_aElectronic books.
700	1		_aMohr, Klaus.
700	1		_aHein, Lutz.
776	0	8	_iPrint version: _aLüllmann, Heinz _tColor Atlas of Pharmacology _dStuttgart : Thieme Medical Publishers, Incorporated,c2017 _z9783132410657
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6187166 _zClick to View
999			_c17964 _d17964